ArticleYonsei medical journal2020

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator.

Hyeok Chan Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.